US CDC approves recommendations for chikungunya vaccines
21/05/2025 23:08
Corrects dateline to May 21 May 21 (Reuters) - The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya, a mosquito-borne virus. The recommendations were approved on May 13, 2025, and are now official recommendations of the CDC. (Reporting by Sneha S K in Bengaluru; Editing by Vijay Kishore) ((Sneha.SK@thomsonreuters.com;))
Recent news on Valneva SE
See all newsBrief: UK MHRA Withdraws Marketing Authorisation for Ixchiq Chikungunya Vaccine After Safety Review
Valneva falls as UK regulator revokes Ixchiq vaccine authorisation
Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency